Avastin again in news: fed ready to consider rescinding approval for MBC

FDA considers revoking approval of Avastin for advanced breast cancer. by Rob Stein, Washington Post, Monday, August 16, 2010

Avastin® (manufactured by Roche, Genentech) makes the news again as the federal government considers the recommendation of a review committee to revoke the approval of Avastin for treating advanced breast cancer.

Questions are rife. Is this a sampling of the government’s trying to control costs, possibly at the expense of the patient? Is it ethically correct to revoke approval when some patients are experiencing success with the drug even though the statistics support a different story? Conceivably, if the FDA revokes approval, insurance companies will probably stop supporting payment for this treatment.

5 6 7 8
© 2004-2010 Donna Peach. All rights reserved.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s